To the Editor: Penicillin resistance has been an increasingproblem in the treatment of infections due to gram-positivecocci over the past 15 years.1 Much of the concern has relatedto the rising minimal inhibitory concentrations (MICs) of antibioticsrequired to suppress Streptococcus pneumoniae, but sharp declinesin penicillin sensitivity have also been observed in streptococciof the viridans group and S. mitis in particular.2,3,4 I reporta case of prosthetic-valve endocarditis resulting from infectionwith an S. mitis organism that was fully resistant to penicillin.
The patient, a 48-year-old man with a long history of intravenousdrug abuse and . . . [Full Text of this Article]
Prabhu, R. M., Piper, K. E., Baddour, L. M., Steckelberg, J. M., Wilson, W. R., Patel, R.
(2004). Antimicrobial Susceptibility Patterns among Viridans Group Streptococcal Isolates from Infective Endocarditis Patients from 1971 to 1986 and 1994 to 2002. Antimicrob. Agents Chemother.
48: 4463-4465
[Abstract][Full Text]
Sabella, C., Murphy, D., Drummond-Webb, J.
(2001). Endocarditis Due to Streptococcus mitis With High-Level Resistance to Penicillin and Ceftriaxone. JAMA
285: 2195-2195
[Full Text]
Mohammed, M. J., Tenover, F. C.
(2000). Evaluation of the PASCO Strep Plus Broth Microdilution Antimicrobial Susceptibility Panels for Testing Streptococcus pneumoniae and Other Streptococcal Species. J. Clin. Microbiol.
38: 1713-1716
[Abstract][Full Text]
Lonks, J. R., Dickinson, B. P., Runarsdottir, V.
(1999). Endocarditis Due to Streptococcus mitis with High-Level Resistance to Penicillin and Cefotaxime. NEJM
341: 1239-1239
[Full Text]